Cervical cancer: open trials in Austria

3 open trials have a site in Austria. Registry data; only the trial team decides who can take part.

NCT07216703
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Medical University of Graz, Graz · Medizinische Universitaet Innsbruck, Innsbruck · Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft mbH, Salzburg · Medical University of Vienna, Vienna
Registry updated 2026-11-06
NCT04989647
Intermediate Risk Cervical Cancer: Radical Surgery +/- Adjuvant Radiotherapy
Trial Treatment · Phase 3 · The Central and Eastern European Gynecologic Oncology Group
Vorarlberger Krankenhaus-Betriebsgesellschaft mbH, Feldkirch · Medical University of Graz, Graz · Steiermaerkische Krankenanstalten Ges.m.b.H., Leoben · Noe LGA Gesundheit Region Mitte GmbH, St. Poelten · Medical University of Vienna, Vienna
Registry updated 2023-09-07
NCT03617133
Image Guided IMRT, Radiochemotherapy and MRI-based IGABT in Locally Advanced Cervical Cancer
Trial Treatment · Phase 2 · Medical University of Vienna
Medical University of Vienna, Vienna
Registry updated 2022-03-17

This page is not medical advice. Talk to your doctor before contacting a trial.

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)